Clopidogrel and Phyllocontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Phyllocontin (aminophylline). Common drug interactions include lip swelling among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Phyllocontin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Phyllocontin?

Phyllocontin has active ingredients of aminophylline. eHealthMe is studying from 547 Phyllocontin users. Check the latest studies of Phyllocontin.



On Jul, 27, 2026

19 people who take Clopidogrel and Phyllocontin together, and have interactions are studied.

Clopidogrel and Phyllocontin drug interactions.

What are the common drug interactions of Clopidogrel and Phyllocontin, by gender? *:

female:

  1. Lip swelling
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Rales (an abnormal respiratory sound characterized by fine crackles)
  5. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Abdominal pain
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Dizziness

male:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Asthenia (weakness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Abasia (inability to walk)
  6. Peripheral swelling

What are the common drug interactions of Clopidogrel and Phyllocontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Cough
  3. Diarrhoea
  4. Lethargy (tiredness)
  5. Lip swelling
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Rales (an abnormal respiratory sound characterized by fine crackles)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Erythema (redness of the skin)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Asthenia (weakness)
  3. Swollen tongue (swelling of tongue)
  4. Dyspnoea (difficult or laboured respiration)
  5. Abasia (inability to walk)
  6. Abdominal pain
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Dizziness
  9. Erythema (redness of the skin)
  10. Hyperhidrosis (abnormally increased sweating)

What are the existing conditions these people have? *

  1. Gout (uric acid crystals building up in the body): 5 people, 26.32%
  2. Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 3 people, 15.79%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 10.53%
  4. Seasonal Allergy (allergic condition due to certain season): 1 person, 5.26%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.26%
  6. Insomnia (sleeplessness): 1 person, 5.26%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
  8. Diarrhea: 1 person, 5.26%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
  10. Asthma: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Phyllocontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopidogrel and Phyllocontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phyllocontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phyllocontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel and aminophylline (the active ingredients of Clopidogrel and Phyllocontin, respectively), and Clopidogrel and Phyllocontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: